Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease arthritis
Phenotype C0032285|pneumonia
Sentences 18
PubMedID- 26029619 Importantly, the background lung parenchymal disease (early-onset chronic obstructive pulmonary disease, rheumatoid arthritis-associated interstitial pneumonia, and combined pulmonary fibrosis and emphysema) was stable upon progression of the right heart failure symptoms/signs, and also during the 3–4-month follow-up period in all cases.
PubMedID- 21467710 Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement.
PubMedID- 21971942 Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (ra) and non-ra rheumatic diseases.
PubMedID- 23212592 Clinical characteristics and risk factors for pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
PubMedID- 20670133 Histologic and immunohistochemical analyses were performed on paraffin sections of the lung tissues from patients with ipf, interstitial pneumonia associated with rheumatoid arthritis, or nonspecific interstitial pneumonia.
PubMedID- 25339568 [acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].
PubMedID- 23124086 [a case of rheumatoid arthritis complicated with deteriorated interstitial pneumonia after the administration of abatacept].
PubMedID- 24495443 Prophylaxis for pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
PubMedID- 20349068 Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.
PubMedID- 20824796 Trends in hospitalizations for pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the us: 1996-2007.
PubMedID- 23791462 Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (ra-ild).
PubMedID- 20217173 Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large japanese observational cohort, iorra.
PubMedID- 25313341 Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with abatacept.
PubMedID- 26543387 We treated 21 patients with organizing pneumonia (op) associated with rheumatoid arthritis (ra) or related to biological disease-modifying antirheumatic drugs (dmards) at our institution between 2006 and 2014.
PubMedID- 26137341 A diagnosis of interstitial lung disease of the usual interstitial pneumonia (uip) variant due to rheumatoid arthritis was made.
PubMedID- 20585825 Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
PubMedID- 22669023 The absence of typical pneumonia symptoms in a patient with rheumatoid arthritis during tocilizumab and steroid treatment.
PubMedID- 26515134 Our data also provide additional evidence in support of an increased risk of all-cause pneumonia in adults with rheumatoid arthritis, systemic lupus erythematosus, crohn’s disease, and neuromuscular/seizure disorders [13, 22].

Page: 1